NEVRO CORP. 2024-2025 Proxy Voting Records

Description as filed by funds: To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 6, 2025, by and among Globus Medical, Inc., a Delaware corporation ("Globus"), Palmer Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Globus ("Merger Sub"), and Nevro Corp., a Delaware corporation ("Nevro"), pursuant to which Merger Sub will be merged with and into Nevro, with Nevro surviving as a wholly owned subsidiary of Globus (the "Merger");

NEVRO CORP.’s own tally for this item (“1. Proposal No. 1 - The Merger Proposal: To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated as of February 6, 2025, by and among Globus Medical, Inc., a Dela”): 28,350,441 for, 684,453 against — passed, per its Form 8-K filed April 2, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Merger Proposal was approved by the requisite vote of Nevro's stockholders.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 10,080,427 for, 51,570 abstained.

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

Description as filed by funds: TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES IF NECESSARY TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES IN PERSON OR BY PROXY TO APPROVE THE PROPOSAL TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.

The 45 asset managers below reported 9,163,293 for, 917,124 against, 51,570 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.

Description as filed by funds: To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Nevro's named executive officers that is based on or otherwise relates to the Merger; and

NEVRO CORP.’s own tally for this item (“2. Proposal No. 2 - The Merger Compensation Proposal: To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Nevro's named executive officers that is based on or ”): 9,661,595 for, 17,932,514 against — failed, per its Form 8-K filed April 2, 2025 (Item 5.07).

Reported outcome: Not approved, in the filing’s own words: “The Merger Compensation Proposal did not receive the requisite vote of Nevro's stockholders and was therefore not approved.”
Support: 35% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 45 managers: 811,022 for, 9,320,965 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 116 managers: 5,637,084 for, 12,622,182 against, 1,463,800 abstained. Showing the 25 largest; see all in the interactive database.

The 4 asset managers below reported 224 for, 45,746 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.